| Home > Publications Database > Delineating mouse β-cell identity during lifetime and in diabetes with a single cell atlas. |
| Journal Article | DZNE-2023-00958 |
; ; ; ; ; ; ; ; ; ;
2023
Springer Nature
[London]
This record in other databases:
Please use a persistent id in citations: doi:10.1038/s42255-023-00876-x
Abstract: Although multiple pancreatic islet single-cell RNA-sequencing (scRNA-seq) datasets have been generated, a consensus on pancreatic cell states in development, homeostasis and diabetes as well as the value of preclinical animal models is missing. Here, we present an scRNA-seq cross-condition mouse islet atlas (MIA), a curated resource for interactive exploration and computational querying. We integrate over 300,000 cells from nine scRNA-seq datasets consisting of 56 samples, varying in age, sex and diabetes models, including an autoimmune type 1 diabetes model (NOD), a glucotoxicity/lipotoxicity type 2 diabetes model (db/db) and a chemical streptozotocin β-cell ablation model. The β-cell landscape of MIA reveals new cell states during disease progression and cross-publication differences between previously suggested marker genes. We show that β-cells in the streptozotocin model transcriptionally correlate with those in human type 2 diabetes and mouse db/db models, but are less similar to human type 1 diabetes and mouse NOD β-cells. We also report pathways that are shared between β-cells in immature, aged and diabetes models. MIA enables a comprehensive analysis of β-cell responses to different stressors, providing a roadmap for the understanding of β-cell plasticity, compensation and demise.
Keyword(s): Humans (MeSH) ; Animals (MeSH) ; Mice (MeSH) ; Aged (MeSH) ; Mice, Inbred NOD (MeSH) ; Diabetes Mellitus, Type 1: genetics (MeSH) ; Diabetes Mellitus, Type 2: genetics (MeSH) ; Streptozocin (MeSH) ; Disease Models, Animal (MeSH) ; Streptozocin
|
The record appears in these collections: |